An Analysis of Subject Recruitment Issues for an HCV Investigational Drug Clinical Trial
Lander, Aitemad A.
MetadataShow full item record
Chronic hepatitis C infection is debilitating, and investigational drugs currently in phase III clinical trials are promising. It is important that efficient antiviral medication reach market if it has the potential for inhibiting viral replication. Because of subject recruitment issues, many studies fail to meet enrollment goals and therefore cannot complete the clinical trial process and bring drugs to market. Therefore, a recruitment plan must be implemented that will ensure that enrollment goals are met. The goal of this practicum was to test the hypothesis that educating the medical and non-medical community about the HCV clinical trials would increase subject enrollment. However, due to certain limitations, not enough data was gathered to provide clear and concise results.